Author:
Blagden S P,Molife L R,Seebaran A,Payne M,Reid A H M,Protheroe A S,Vasist L S,Williams D D,Bowen C,Kathman S J,Hodge J P,Dar M M,de Bono J S,Middleton M R
Publisher
Springer Science and Business Media LLC
Reference31 articles.
1. Baker SD, Zhao M, Lee CKK, Verweij J, Zabelina Y, Brahmer JR, Wolff AC, Sparreboom A, Carducci MA (2003) Comparative Pharmacokinetics of weekly and every three weeks docetaxel. Clin Cancer Res 10: 1976–1983
2. Blagden S, de Bono J (2005) Drugging cell cycle kinases in cancer therapy. Curr Drug Targets 6: 325–335
3. Blangy A, Lane HA, d'Herin P, Harper M, Kress M, Nigg EA (1995) Phosphorylation by p34cdc2 regulates spindle association of human Eg5, a kinesin-related motor essential for bipolar spindle formation in vivo. Cell 83: 1159–1169
4. Bubley GJ, Carducci M, Dahut W, Dawson N, Daliani D, Eisenberger M, Figg WD, Freidlin B, Halabi S, Hudes G, Hussain M, Kaplan R, Myers C, Oh W, Petrylak DP, Reed E, Roth B, Sartor O, Scher H, Simons J, Sinibaldi V, Small EJ, Smith MR, Trump DL, Vollmer R, Wilding G (1999) Eligibility and response guidelines for phase II clinical trials in androgen-independent prostate cancer: recommendations from the Prostate-Specific Antigen Working Group. J Clin Oncol 17: 3461–3467
5. Burris HA, Lorusso P, Jones S, Guthrie TM, Orr JB, Williams DD, Hodge JP, Bush M, Sabry J (2004) Phase I trial of novel kinesin spindle protein (KSP) inhibitor SB-715992 IV days 1, 8 15 q 28 days. Proc Am Soc Clin Oncol 22: 14S
Cited by
67 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献